Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
75,239 questions in 5,342 reviews
current versionsNo studies 15,213 · 20.2%Ungraded 10,323 · 13.7%Very low 17,528 · 23.3%Low 17,951 · 23.9%Moderate 11,190 · 14.9%High 3,034 · 4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
White noise vs standard care Physiological indicators · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | no estimate extracted | NR | No studies |
Facilitated tucking / four‐handed care / gentle human touch vs standard care PIPP during endotracheal suctioning Range of scale 0 to 21. Lower score = less pain · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | no estimate extracted | 4 studies · 148 participants | Moderate |
White noise vs standard care Heart rate · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | no estimate extracted | 1 study · 40 participants | Low |
White noise vs standard care SaO 2 · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | MD 2.25 | 1 study · 40 participants | Low |
White noise vs standard care Behavioural indicators · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | no estimate extracted | NR | No studies |
White noise vs standard care — · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | no estimate extracted | NR | No studies |
Facilitated tucking / four‐handed care / gentle human touch vs standard care Physiological indicators · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | no estimate extracted | NR | No studies |
Facilitated tucking / four‐handed care / gentle human touch vs standard care Heart rate · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | no estimate extracted | 2 studies · 80 participants | Low |
Facilitated tucking / four‐handed care / gentle human touch vs standard care SaO 2 during endotracheal suctioning · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | MD 0.87 | 2 studies · 80 participants | Low |
Facilitated tucking / four‐handed care / gentle human touch vs standard care Behavioural indicators · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | no estimate extracted | NR | No studies |
Facilitated tucking / four‐handed care / gentle human touch vs standard care SDB during endotracheal suctioning · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | no estimate extracted | 1 study · 20 participants | Low |
Facilitated tucking / four‐handed care / gentle human touch vs standard care SRB during endotracheal suctioning · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | MD 0.9 [0.2, 1.6] | 1 study · 20 participants | Low |
Facilitated tucking / four‐handed care / gentle human touch vs standard care — · neonates with mechanical ventilation Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane | no estimate extracted | NR | No studies |
Mindfulness‐based interventions (MBIs) vs active comparators Clinical CVD events · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Mindfulness‐based interventions (MBIs) vs non‐active comparators Clinical CVD events (CVD mortality and non‐fatal MI) · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | RR 0.94 [0.37, 2.42] | 1 study · 110 participants | Very low |
Mindfulness‐based interventions (MBIs) vs non‐active comparators Systolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 9 studies · 379 participants | Low |
Mindfulness‐based interventions (MBIs) vs non‐active comparators Diastolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 9 studies · 379 participants | Low |
Mindfulness‐based interventions (MBIs) vs non‐active comparators Anxiety, change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 9 studies · 533 participants | Low |
Mindfulness‐based interventions (MBIs) vs non‐active comparators Depression, change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 15 studies · 912 participants | Low |
Mindfulness‐based interventions (MBIs) vs non‐active comparators Perceived stress, change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 11 studies · 708 participants | Low |
Mindfulness‐based interventions (MBIs) vs non‐active comparators Well‐being · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 2 studies · 198 participants | Moderate |
Mindfulness‐based interventions (MBIs) vs non‐active comparators Adverse events · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | RR 5 [0.27, 91.52] | 1 study · 18 participants | Low |
Mindfulness‐based interventions (MBIs) vs non‐active comparators Smoking cessation · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | RR 1.36 [0.86, 2.13] | 2 studies · 453 participants | Low |
Transcendental meditation (TM) vs active comparators Clinical CVD events (CVD mortality, non‐fatal MI and stroke, revascularisations) · people at high risk of or with cardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | RR 0.91 [0.56, 1.49] | 1 study · 201 participants | Low |
Mindfulness‐based interventions (MBIs) vs active comparators Systolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 6 studies · 388 participants | Low |
Transcendental meditation (TM) vs active comparators Systolic blood pressure (mmHg), change from baseline · people at high risk of or with cardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 8 studies · 774 participants | Moderate |
Transcendental meditation (TM) vs active comparators Diastolic blood pressure (mmHg), change from baseline · people at high risk of or with cardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 8 studies · 774 participants | Low |
Transcendental meditation (TM) vs active comparators Anxiety, change from baseline · people at high risk of or with cardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 3 studies · 200 participants | Low |
Transcendental meditation (TM) vs active comparators Depression, change from baseline · people at high risk of or with cardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 5 studies · 421 participants | Moderate |
Transcendental meditation (TM) vs active comparators Perceived stress, change from baseline · people at high risk of or with cardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 3 studies · 194 participants | Very low |
Transcendental meditation (TM) vs active comparators Well‐being · people at high risk of or with cardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Transcendental meditation (TM) vs active comparators Adverse events · people at high risk of or with cardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Transcendental meditation (TM) vs active comparators Smoking cessation · people at high risk of or with cardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Transcendental meditation (TM) vs non‐active comparators Clinical CVD events · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Transcendental meditation (TM) vs non‐active comparators Systolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 2 studies · 139 participants | Low |
Mindfulness‐based interventions (MBIs) vs active comparators Diastolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 6 studies · 388 participants | Low |
Transcendental meditation (TM) vs non‐active comparators Diastolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 2 studies · 139 participants | Low |
Transcendental meditation (TM) vs non‐active comparators Anxiety, change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 1 study · 112 participants | Low |
Transcendental meditation (TM) vs non‐active comparators Depression, change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 1 study · 112 participants | Low |
Transcendental meditation (TM) vs non‐active comparators Perceived stress · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Transcendental meditation (TM) vs non‐active comparators Well‐being · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Transcendental meditation (TM) vs non‐active comparators Adverse events · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Transcendental meditation (TM) vs non‐active comparators Smoking cessation · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Mindfulness‐based interventions (MBIs) vs active comparators Anxiety, change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 9 studies · 438 participants | Moderate |
Mindfulness‐based interventions (MBIs) vs active comparators Depression, change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 11 studies · 595 participants | Moderate |
Mindfulness‐based interventions (MBIs) vs active comparators Perceived stress, change from baseline · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 6 studies · 357 participants | Moderate |
Mindfulness‐based interventions (MBIs) vs active comparators Well‐being · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | 1 study · 63 participants | Low |
Mindfulness‐based interventions (MBIs) vs active comparators Adverse events · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Mindfulness‐based interventions (MBIs) vs active comparators Smoking cessation · people at high risk of or withcardiovascular disease Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane | RR 1.45 [0.78, 2.68] | 6 studies · 1087 participants | Low |
TG4010 added to chemotherapy vs chemotherapy alone Overall survival · adults with advanced non‐small cell lung cancer (NSCLC) Therapeutic vaccines for advanced non‐small cell lung cancer (2024) · Cochrane | HR 0.83 [0.65, 1.05] | 2 studies · 370 participants | Low |